|
PLK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.771610E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.359000E-01 |
| Normal-vs-Stage2 |
2.435700E-02 |
| Normal-vs-Stage3 |
1.812760E-01 |
| Normal-vs-Stage4 |
3.130200E-01 |
| Stage1-vs-Stage2 |
6.984200E-04 |
| Stage1-vs-Stage3 |
6.322800E-01 |
| Stage1-vs-Stage4 |
8.365600E-01 |
| Stage2-vs-Stage3 |
1.376150E-02 |
| Stage2-vs-Stage4 |
1.767600E-02 |
| Stage3-vs-Stage4 |
5.797400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.758200E-01 |
| Normal-vs-AfricanAmerican |
5.397500E-02 |
| Normal-vs-Asian |
2.675800E-01 |
| Caucasian-vs-AfricanAmerican |
3.403700E-02 |
| Caucasian-vs-Asian |
8.686800E-01 |
| AfricanAmerican-vs-Asian |
1.217220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.199600E-01 |
| Normal-vs-Female |
1.677990E-01 |
| Male-vs-Female |
6.529400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.412200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.176200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.245800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.439600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.196000E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.936200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.657180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.213160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.159700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.546000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.816800E-01 |
| Classical-VS-Follicular |
1.360710E-04 |
| Classical-VS-Other |
8.888000E-02 |
| Classical-VS-Normal |
2.796400E-01 |
| Tall-VS-Follicular |
2.385800E-02 |
| Tall-VS-Other |
2.159800E-01 |
| Tall-VS-Normal |
3.436200E-01 |
| Follicular-VS-Other |
4.762200E-01 |
| Follicular-VS-Normal |
2.473800E-02 |
| Other-VS-Normal |
7.158000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.308450E-01 |
| Normal-vs-N1 |
1.174960E-01 |
| N0-vs-N1 |
8.134200E-01 |
|
|
